Table 2.

Baseline subject demographics.

	All (N = 141)	MIS (N = 69)	XL (N = 72)	p-value
Age (years)	56.8 (13.4)	57.1 (11.5)	56.5 (15.0)	0.81
Race (ethnicity)
Caucasian	104 (73.8)	54 (78.3)	50 (69.4)	0.43
Black	17 (12.1)	6 (8.7)	11 (15.3)
Hispanic	13 (9.2)	7 (10.1)	6 (8.3)
Other	5 (3.5)	2 (2.9)	3 (4.2)
Unknown	2 (1.4)	0 (0)	2 (2.8)
Body mass index	32.6 (9.2)	34.6 (8.9)	30.7 (9.1)	0.01
ECOG functional status				0.74
0	129 (91.5)	65 (94.2)	64 (88.9)
1	10 (7.1)	4 (5.8)	6 (8.3
2	1 (0.7)	0 (0)	1 (1.4)
Medical comorbidities
Hypertension	55 (39)	22 (31.9)	33 (45.8)	0.09
Cardiac disease	13 (9.2)	5 (7.2)	8 (11.1)	0.43
Diabetes	21 (14.9)	10 (14.5)	11 (15.3)	0.90
Psychiatric diagnosis	28 (19.9)	9 (13.0)	19 (26.4)	0.05
Total no. of comorbidities	2 (0–12)	2 (0–12)	2.5 (0–9)	0.08
Tobacco use				0.21
Never smoker	71 (50.4)	40 (58)	31 (43.1)
Former smoker	51 (36.2)	21 (30.4)	30 (41.7)
Current smoker	19 (13.5)	8 (11.6)	11 (15.3)
Pre-op Hgb (g/dl)	12.9 (1.4)	13.1 (1.2)	12.6 (1.6)	0.03
Pre-op albumin (g/dl)	3.8 (0.4)	3.9 (0.3)	3.8 (0.5)	0.07
Prior radiation	5 (3.5)	3 (4.3)	2 (2.8)	0.68
Prior abdominal surgery	92 (65.2)	40 (58.0)	52 (72.2)	0.09
Indication for surgery				<0.001
Endometrial CA/EIN	50 (35.5)	37 (53.6)	13 (18.1)
Ovarian ca	7 (5.0)	0 (0)	7 (9.7)
Cervical ca	4 (2.8)	3 (4.3)	1 (1.4)
Cervical dysplasia	10 (7.1)	7 (10.1)	3 (4.2)
Adnexal mass	47 (33.3)	9 (13.0)	38 (52.8)
Postmenopausal bleeding	8 (5.7)	6 (8.7)	2 (2.8)
Risk-reducing surgery	8 (5.7)	7 (10.1)	1 (1.4)
Leiomyoma/pelvic pain	7 (5.0)	0 (0)	7 (8.3)

Pre-op, preoperative; Hgb, hemoglobin; ca, cancer; EIN, endometrial intraepithelial neoplasia.

Data presented as mean (standard deviation), median (range), and n (%) as indicated. Numbers may not add to the total due to missing values.